Dr. Wang Junqi, a postdoctoral fellow from Yale University and Ph.D. in Analytical Chemistry from the University of Michigan, stands as a leading figure in global micro gas chromatography (micro-GC) technology. He co-founded and spearheaded the commercialization of two U.S.-based companies, Targeted Compound Monitoring, LLC and HKF Technology, where he served as Chief Technology Officer to develop core technologies and products for HKF. With 18 published papers, including 8 in Chinese Academy of Sciences Tier-1 journals, his groundbreaking research has been featured in top-tier publications such as Nature's Microsystems & Nanoengineering and Analytical Chemistry. He has delivered keynote speeches at prestigious international conferences like IEEE Transducers & Eurosensors, and has been invited to share insights at Harvard University, Yale University, Merck & Co., and The Dow Chemical Company.

Recognized as a National Entrepreneurial Talent by China's Ministry of Industry and Information Technology, Dr. Wang leads multiple national innovation initiatives, including the National Disruptive Technology Innovation Key Project and the Key Entrepreneurial Program for Overseas Returnees under the Ministry of Human Resources. He has been honored as Guangzhou's Innovation and Entrepreneurship Leader and included in the Guangzhou Science and Technology Experts Database. His accolades span prestigious titles such as Fortune China's "40 Under 40 Most Promising Business Leaders," "Top 10 Rising Stars in Guangdong Business," "36Under36 Entrepreneurial Pioneer" by 36Kr, and "2023 Innovator of the Year" among the Top 50 Biotech Innovators in the Greater Bay Area. Currently, he serves as Executive Council Member of the Chinese Research Hospital Association and Standing Director of the Youth Committee at the Guangdong Chamber of Commerce, driving cross-industry collaboration and scientific innovation.